In conclusion, the relationships between PD-1/PD-L1 expression and polarization in TAMs seem to be crucial in tumor progression, indicating that combination immunotherapy targeting these cells will likely become a trend in checkpoint blockade therapy [109]. This evidence concerns the gene CD274 and neoplasm.